APOE4, a form of the human apolipoprotein E gene, is a genetic risk factor for Alzheimer’s disease (AD) and is also associated with other forms of neuropathology. APOE4 is thought to compromise the blood-brain barrier (BBB), but the underlying mechanisms have been unclear. Bell et al. addressed this issue by studying the brain microvasculature in several strains of genetically engineered mice: one lacking the mouse Apoe gene, and others expressing human APOE2, APOE3 or APOE4. They found that Apoe−/− and APOE4 mice, but not APOE2 or APOE3 mice, had severe BBB defects that were caused by defective regulation of the levels of cyclophilin A (CypA). Increased levels of CypA in Apoe−/− and APOE4 mice caused activation of NFκB, which in turn increased the expression and activation of MMP-9 in pericytes, which surround the microvasculature. Higher levels of active MMP-9 were shown to compromise BBB integrity in Apoe−/− and APOE4 mice; notably, effects on the vasculature preceded neurodegeneration. Genetic ablation or pharmacological inhibition of CypA restored the BBB, as did an MMP-9 inhibitor. These results broaden our understanding of how APOE4 might compromise the BBB and thereby contribute to AD and other neuropathologies.
APOE4 impairs blood-brain barrier via cyclophilin A
APOE4 impairs blood-brain barrier via cyclophilin A. Dis Model Mech 1 July 2012; 5 (4): 415. doi:
Download citation file:
Advertisement
Cited by
DMM Journal Meeting 2024: Pre-clinical Modelling of Human Genetic Disease and Therapy

Registration is now open for our 2024 Journal Meeting. Rapid advances in gene editing and genetic technologies have revolutionised our ability to model human genetic disease and provided new hope for gene therapies. At this Meeting, we will present the very latest advances in modelling human genetic disease.
A new call for papers is underway

Showcase your latest research in our upcoming special issue Translating Multiscale Research in Rare Disease, coordinated by DMM Editors Monica Justice, Karen Liu and Monkol Lek, and Guest Editor Kate Rauen. The deadline for submitting articles to the special issue is Monday 6 November 2023.
Moving towards heart success – Disease Models & Mechanisms Special Issue

DMM's most recent special issue compiles articles that aim to move heart failure to heart success by fundamentally addressing the roots of failure to identify curative strategies.
Adult zebrafish as advanced models of human disease

Editor-in-Chief Liz Patton and Editorial Board member Rich White discuss the unique advantages of adult zebrafish for studying human disease biology. Read the Open Access Editorial here.
The Forest of Biologists

The Forest of Biologists is a biodiversity initiative created by The Company of Biologists, with support from the Woodland Trust. For every Research and Review article published in Disease Models & Mechanisms a native tree is planted in a UK forest. In addition to this we are protecting and restoring ancient woodland and are dedicating these trees to our peer reviewers. Visit our virtual forest to learn more.
Other journals from
The Company of Biologists